Shire Regenerative Medicine, Inc.
Shire Regenerative Medicine, Inc., a leader in the regenerative medicine industry, is headquartered in the United States and operates across key regions globally. Founded in 2008, the company has made significant strides in developing innovative therapies that harness the body’s natural healing processes.
Shire focuses on advanced cell and gene therapies, offering unique products that address unmet medical needs in areas such as orthopaedics and wound care. Their commitment to research and development has positioned them as a notable player in the regenerative medicine market, with a reputation for pioneering solutions that enhance patient outcomes.
With a strong emphasis on scientific excellence and patient-centric approaches, Shire Regenerative Medicine continues to set benchmarks in the industry, driving forward the future of healing and recovery.
+16 vs industry average
Shire Regenerative Medicine, Inc.’s score of 54 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Shire Regenerative Medicine, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Shire Regenerative Medicine, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Shire Regenerative Medicine, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Shire Regenerative Medicine, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Takeda Pharmaceutical Company Limited
Carbon Disclosure Project
Inherited from Takeda Pharmaceutical Company LimitedThe Climate Pledge
UN Global Compact Climate Champions initiative
Inherited from Takeda Pharmaceutical Company LimitedRE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project